ERN1 and plasma cell myeloma: Our data and the results from these forementioned study suggest that activation of the IRE1α-XBP1 pathway via PIs might contribute to a better clinical course via not only the direct cytotoxicity of those drugs but also through the long-term effects of the immunological memory obtained after ICD of myeloma cells.